These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26963025)

  • 61. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ex vivo
    Portelius E; Mattsson N; Pannee J; Zetterberg H; Gisslén M; Vanderstichele H; Gkanatsiou E; Crespi GA; Parker MW; Miles LA; Gobom J; Blennow K
    Mol Neurodegener; 2017 Feb; 12(1):18. PubMed ID: 28219449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progesterone suppresses Aβ
    Hong Y; Liu Y; Zhang G; Wu H; Hou Y
    Int Immunopharmacol; 2018 Jan; 54():336-343. PubMed ID: 29197800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.
    Kochkina EG; Plesneva SA; Vasilev DS; Zhuravin IA; Turner AJ; Nalivaeva NN
    Biogerontology; 2015 Aug; 16(4):473-84. PubMed ID: 25792373
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
    J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.
    Wilhelmus MM; de Jager M; Smit AB; van der Loo RJ; Drukarch B
    Sci Rep; 2016 Feb; 6():20569. PubMed ID: 26837469
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme.
    Abramov-Harpaz K; Miller Y
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    Meeker KD; Meabon JS; Cook DG
    J Alzheimers Dis; 2015; 45(2):509-20. PubMed ID: 25589729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families.
    Kim M; Hersh LB; Leissring MA; Ingelsson M; Matsui T; Farris W; Lu A; Hyman BT; Selkoe DJ; Bertram L; Tanzi RE
    J Biol Chem; 2007 Mar; 282(11):7825-32. PubMed ID: 17244626
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
    Lin F; Jia J; Qin W
    Neuroreport; 2014 Nov; 25(16):1289-95. PubMed ID: 25202927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion.
    Kim YH; Kwak MS; Lee B; Shin JM; Aum S; Park IH; Lee MG; Shin JS
    Autophagy; 2021 Sep; 17(9):2345-2362. PubMed ID: 33017561
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extracellular Matrix Remodeling Alleviates Memory Deficits in Alzheimer's Disease by Enhancing the Astrocytic Autophagy-Lysosome Pathway.
    Yang Q; Yan C; Sun Y; Xie Z; Yang L; Jiang M; Ni J; Chen B; Xu S; Yuan Z; Wu Y; Liu X; Yuan Z; Bai Z
    Adv Sci (Weinh); 2024 Aug; 11(31):e2400480. PubMed ID: 38881515
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review.
    Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M
    Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β.
    Dupont N; Jiang S; Pilli M; Ornatowski W; Bhattacharya D; Deretic V
    EMBO J; 2011 Nov; 30(23):4701-11. PubMed ID: 22068051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
    Cabrol C; Huzarska MA; Dinolfo C; Rodriguez MC; Reinstatler L; Ni J; Yeh LA; Cuny GD; Stein RL; Selkoe DJ; Leissring MA
    PLoS One; 2009; 4(4):e5274. PubMed ID: 19384407
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque.
    Kulstad JJ; McMillan PJ; Leverenz JB; Cook DG; Green PS; Peskind ER; Wilkinson CW; Farris W; Mehta PD; Craft S
    J Neuropathol Exp Neurol; 2005 Feb; 64(2):139-46. PubMed ID: 15751228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.